I'm LongbridgeAI, I can summarize articles.Danaher Corp. (DHR) shares fell 2.11% to $200.53 on Thursday, underperforming competitors like Thermo Fisher Scientific and Abbott Laboratories during a broader market decline. This marks the fourth consecutive day of losses for Danaher, which is now trading 17.41% below its 52-week high. Trading volume remained below the 50-day average.
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Danaher Corp. (DHR) shed 2.11% to $200.53 Thursday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index falling 0.58% to 7,591.70 and Dow Jones Industrial Average falling 0.60% to 52,064.10.
This was the stock's fourth consecutive day of losses.
Danaher Corp. closed 17.41% below its 52-week high of $242.80, which the company reached on January 22nd.
The stock underperformed when compared to some of its competitors Thursday, as Thermo Fisher Scientific Inc. (TMO) fell 0.41% to $603.18, Abbott Laboratories (ABT) fell 1.78% to $103.36, and Medtronic PLC (MDT) fell 0.29% to $91.62.
Trading volume (2.9 M) remained 1.7 million below its 50-day average volume of 4.7 M.
Data source: Dow Jones Market Data, FactSet. Data compiled September 10, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
09-10-26 1637ET